<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27737409</article-id><article-id pub-id-type="pmc">5062704</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160026</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Fungal Endocarditis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Shi-Min</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MMed, PhD</role></contrib><aff id="aff1"><label>1</label>The First Hospital of Putian, Teaching Hospital,
Fujian Medical University, Fujian Province, China</aff></contrib-group><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Shi-Min Yuan, Longdejing
Street, 389 - Chengxiang District, Putian, Fujian Province, People's Republic of
China. E-mail: <email>shiminyuan@126.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2016</year></pub-date><volume>31</volume><issue>3</issue><fpage>252</fpage><lpage>255</lpage><history><date date-type="received"><day>28</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Fungal endocarditis is a rare and fatal condition. The <italic>Candida</italic>
and <italic>Aspergillus</italic> species are the two most common etiologic fungi
found responsible for fungal endocarditis. Fever and changing heart murmur are
the most common clinical manifestations. Some patients may have a fever of
unknown origin as the onset symptom. The diagnosis of fungal endocarditis is
challenging, and diagnosis of prosthetic valve fungal endocarditis is extremely
difficult. The optimum antifungal therapy still remains debatable. Treating
<italic>Candida</italic> endocarditis can be difficult because the
<italic>Candida</italic> species can form biofilms on native and prosthetic
heart valves. Combined treatment appears superior to monotherapy. Combination of
antifungal therapy and surgical debridement might bring about better
prognosis.</p></abstract><kwd-group><kwd>Antifungal Agents</kwd><kwd>Endocarditis</kwd><kwd>Fungi</kwd></kwd-group></article-meta></front><body><p><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Abbreviations, acronyms &#x00026;
symbols</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AMB</td><td rowspan="1" colspan="1">= Amphotericin B</td></tr><tr><td rowspan="1" colspan="1">ESCMID</td><td rowspan="1" colspan="1">= European Society of Clinical Microbiology and Infectious
Diseases</td></tr><tr><td rowspan="1" colspan="1">FE</td><td rowspan="1" colspan="1">= Fungal endocarditis</td></tr></tbody></table></table-wrap>
</p><sec sec-type="intro"><title>INTRODUCTION</title><p>Fungal endocarditis (FE) remains the most serious form of infective endocarditis,
with a high mortality rate of about 50%<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. It is fatal,
usually being diagnosed postmortem<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. It is highly challenging to identify the source, to establish
a diagnosis, and to carry out the treatment<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The etiologic fungi more commonly seen are the
<italic>Candida</italic> and <italic>Aspergillus</italic> species. They can be
isolated from surgically removed emboli, resected valves, or infected foreign
bodies<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. <italic>Candida
albicans</italic> is responsible for 24-46% of all the cases of FE and for 3.4%
of all the cases of prosthetic valve endocarditis, with a mortality rate of
46.6-50%. After <italic>Candida</italic>, the A<italic>spergillus</italic> species
are the second most frequent pathogens of fungal infection, accounting for
approximately 25% of all FE cases in cardiac valve prostheses and the great
vessels<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. With increasing
age, the incidence of <italic>Candida</italic> FE decreases whereas the incidence of
<italic>Aspergillus</italic> FE increases<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. The affected cardiac sites in neonates significantly
differ from those of adults (mitral or aortic valve) with the right atrium being
predominant in 63% of neonates<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p></sec><sec><title>RISK FACTORS</title><p>Previous surgery and intravenous drug use were once reported to be the most frequent
risk factors for development of FE. Other risk factors included parenteral
nutrition, immunosuppression, underlying cardiac abnormalities, prosthetic heart
valves, indwelling central venous catheters, prolonged use of broad-spectrum
antibiotics, and cardiovascular surgery. Evolving myelodysplastic syndrome, use of
steroid and cytotoxic drugs, and bone marrow transplantation with a high dose of
immunosuppressive therapy are the major predisposing risk factors<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Multifactorial risk factors in a
single patient might be more likely to cause FE, and coinfections of fungi and
bacterium could be a refractory condition<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>.</p></sec><sec><title>CLINICAL PRESENTATIONS</title><p>Fever was present in all the patients and changing heart murmur was recorded in some
of them. Some patients presented with fever of unknown origin and surgical
procedures were eventually required<sup>[<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Other clinical
signs, such as dyspnea, cough, general body pain, lower extremity pain, and finger
clubbing were detected in a few cases<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Dwarakanath et al.<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> reported a patient with multi-chambered FE presenting with
sudden onset of angina with elevated troponins. White blood cell count could be
slightly increased to between 4,800 and 12,300 cells/mL<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Blood cultures of <italic>Aspergillus</italic>
pathogens are negative in over 50% of patients with <italic>Aspergillus</italic>
endocarditis<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p></sec><sec><title>DIAGNOSIS</title><p>The diagnosis of FE is challenging. Diagnosis of prosthetic valve FE is extremely
difficult because its clinical manifestations are similar to bacterial endocarditis.
In a review of 91 patients with <italic>Candida</italic> endocarditis, 77% of them
were diagnosed after autopsy<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>.
Shokohi et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> reported that
prosthetic valve FE occurred three years after surgery as a late consequence. Ellis
et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> reported that the
sensitivity of transthoracic and transesophageal echocardiography techniques
specifically focused on FE reached 77%. Transthoracic echocardiography provides
valuable information for the diagnosis of <italic>Aspergillus</italic> endocarditis,
identifying vegetations for 89% and 77% of native and prosthetic valve endocarditis,
respectively<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. A
histopathological examination of the vegetation tissue demonstrated a large fungal
mass widely distributed around the site of vegetation without obvious inflammatory
cell infiltration, which appeared to correspond to FE<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Accurate molecular methods were available for
the diagnosis of many infections, which were as much as 3-fold more sensitive than
Gram staining and culture<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.
Badiee et al.<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup> reported that
polymerase chain reaction was positive in all tissue samples and in 10/11 blood
samples<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p></sec><sec><title>TREATMENT</title><p>The optimum antifungal therapy still remains debatable. Treating
<italic>Candida</italic> endocarditis can be difficult because
<italic>Candida</italic> species can form biofilms on native and prosthetic
heart valves that can lead to poor antifungal activity of those agents. Voriconazole
is active against a wide spectrum of clinically important fungi, including
<italic>Candida, Aspergillus</italic> and <italic>Fusarium</italic>.
Amphotericin B (AMB) has been used in the management of <italic>Aspergillus</italic>
endocarditis. AMB is less toxic than the conventional amphotericin and it can be
administered at higher doses, especially indicated for a patient who has impaired
renal function or who develops nephrotoxicity while receiving classic
amphotericin<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. AMB alone
cannot effectively penetrate and cure vegetations associated with FE<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Itraconazole and caspofungin are
effective for the treatment of refractory <italic>Aspergillus</italic> infection.
Echinocandins have low toxicity and limited drug interactions compared to other
antifungal drugs. It is as effective as AMB in non-neutropenic patients with
<italic>Aspergillus</italic> infection<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Combined treatment appears to be superior to monotherapy. Simultaneous inhibition of
fungal cell-wall and cell-membrane biosynthesis may result in synergistic
interaction against <italic>Aspergillus fumigatus</italic>. The combination of
caspofungin with either AMB or voriconazole may exert a synergistic
effect<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. The
combination of voriconazole with caspofungin can be another alternative approach for
FE<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Furthermore, the
addition of flucytosine, or 5-flurocytosine, synergistically improves the antifungal
efficacy of AMB<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Micafungin in
combination with ravuconazole against experimental invasive pulmonary aspergillosis
in persistently neutropenic rabbits led to significant reductions in mortality,
residual fungal burden and serum galactomannan antigenemia<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. The resistance occurs through
multiple mechanisms, including decreasing the content of ergosterol in the cell
membrane<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The
Infectious Diseases Society of America 2009 Candidiasis Guidelines recommended a
combined medical and surgical approach for treatment of <italic>Candida</italic>
endocarditis<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Current
endocarditis guidelines recommend initial or induction therapy with AMB with or
without flucytosine combined with surgical removal of vegetation, followed by
chronic suppressive therapy with oral fluconazole<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>Indications of surgical intervention are the risk of disseminated infected emboli,
increased mobility of the mass, progressive enlargement of mass while on treatment
and the hemodynamic instability of the neonate<sup>[<xref rid="r24" ref-type="bibr">24</xref>-<xref rid="r26" ref-type="bibr">26</xref>]</sup>, congestive
heart failure, valve dehiscence, perivalvular abscess, and declined
surgery<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Prolonged
broad spectrum antibiotic therapy is necessary<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>. Concerning the 100% mortality rate among those who
receive medical treatment alone, an early and aggressive surgical approach is
recommended before the onset of valvular destruction, fatal embolic attacks, or
chordae rupture causing acute mitral valve insufficiency<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. Successful treatment of
<italic>Aspergillus</italic> endocarditis requires the combination of antifungal
therapy and surgical debridement<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. There is conflicting data on outcomes associated with the
combined medical and surgical approach <italic>versus</italic> medical therapy
alone<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup>. According to
the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
guidelines for the diagnosis and management of <italic>Candida</italic> diseases,
adult patients with native valve <italic>Candida</italic> endocarditis should
undergo surgical treatment within one week combined with antifungal treatment
consisting of liposomal AMB or caspofungin for 6-8 weeks, with or without additional
flucytosine, followed by fluconazole<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>.</p></sec><sec><title>OUTCOMES</title><p>Early detection and prompt initiation of appropriate treatment could reduce mortality
from FE<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The early experiences
of management protocol and the outcomes of FE summarized by Seelig et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup> showed a negative correlation
between the severity of FE and the patients' prognoses (<xref ref-type="fig" rid="f1">Figure 1</xref>). <italic>Aspergillus</italic> endocarditis is more
commonly associated with embolic phenomena than bacterial endocarditis. The organs
most frequently involved are the brain, kidneys, spleen and lungs. Myocardial
infarction due to <italic>Aspergillus</italic> embolism often complicates the
differential diagnosis of common myocardial infarction<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The use of recombinant tissue plasminogen
activator is based on the standpoint that FE vegetations represent a complex and
heterogenic mass, consisting not only of colonizing fungus but also of platelets and
fibrin<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>. After surgical
debridement and antifungal treatment with AMB or voriconazole, the 12-month survival
rate was 82%<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Kalokhe et
al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> conducted a
literature review including 53 case reports of <italic>Aspergillus</italic>
endocarditis and found that only 4% of these cases were treated successfully with
antifungal therapy alone. Even with surgical therapy, the survival rate was 32%.
This poor outcome might be in part due to the immunocompromised status of the host,
delayed diagnosis, and rapidity of embolization<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>. The recurrence rate was very high, with fatal prognosis.
An early diagnosis using various diagnostic procedures and early therapy became very
important in immunosuppressed patients. For this reason, empirical use of AMB should
be initiated if an immunosuppressed patient has a persistent fever and antibiotics
are ineffective<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig.1</label><caption><p>Management protocol for fungal endocarditis based on the data summarized
by Seelig et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup>.
FE=fungal endocarditis; MIC=minimum inhibitory concentration;
pt=patients</p></caption><graphic xlink:href="rbccv-31-03-0252-g01"/></fig>
</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>FE is rare, but fatal. The diagnosis and management are challenging. Molecular
methods are the most sensitive way of diagnosing the pathogens. In high-risk
patients presenting prolonged fever, empiric antifungal therapies are necessary and
should be given with sufficient term and dose. Combined treatment shows superior
results to monotherapy. Combination of antifungal therapy and surgical debridement
is the preferred treatment of choice in selected patients.</p><p>
<table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="15%" span="1"/><col width="85%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SMY</td><td rowspan="1" colspan="1">Study conception and design; analysis and/or interpretation of
data; manuscript writing; final approval of the manuscript</td></tr></tbody></table></table-wrap>
</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at The First Hospital of Putian, Teaching Hospital,
Fujian Medical University, Putian, Fujian Province, People's Republic of
China.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badiee</surname><given-names>P</given-names></name><name><surname>Amirghofran</surname><given-names>AA</given-names></name><name><surname>Ghazi Nour</surname><given-names>M</given-names></name><name><surname>Shafa</surname><given-names>M</given-names></name><name><surname>Nemati</surname><given-names>MH</given-names></name></person-group><article-title>Incidence and outcome of documented fungal
endocarditis</article-title><source>Int Cardiovasc Res J</source><year>2014</year><volume>8</volume><issue>4</issue><fpage>152</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">25614858</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierrotti</surname><given-names>LC</given-names></name><name><surname>Baddour</surname><given-names>LM</given-names></name></person-group><article-title>Fungal endocarditis, 1995-2000</article-title><source>Chest</source><year>2002</year><volume>122</volume><issue>1</issue><fpage>302</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">12114375</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>GW</given-names></name><name><surname>Seol</surname><given-names>SH</given-names></name><name><surname>No</surname><given-names>TH</given-names></name><name><surname>Jeong</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>TJ</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Acute myocardial infarction caused by coronary embolism from
Aspergillus endocarditis</article-title><source>Intern Med</source><year>2014</year><volume>53</volume><issue>7</issue><fpage>713</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">24694482</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinstein</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name></person-group><article-title>Fungal endocarditis</article-title><source>Eur Heart J</source><year>1995</year><volume>16</volume><issue>Suppl B</issue><fpage>84</fpage><lpage>89</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>BC</given-names></name><name><surname>Jugo</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>JE</given-names></name></person-group><article-title>Fungal endocarditis in neonates and children</article-title><source>Pediatr Cardiol</source><year>2005</year><volume>26</volume><issue>5</issue><fpage>517</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">15549616</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez Guerrero</surname><given-names>ML</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>B</given-names></name><name><surname>Manzarbeitia</surname><given-names>F</given-names></name><name><surname>Renedo</surname><given-names>G</given-names></name></person-group><article-title>Infective endocarditis at autopsy: a review of pathologic
manifestations and clinical correlates</article-title><source>Medicine (Baltimore)</source><year>2012</year><volume>91</volume><issue>3</issue><fpage>152</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">22543628</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demir</surname><given-names>T</given-names></name><name><surname>Ergenoglu</surname><given-names>MU</given-names></name><name><surname>Ekinci</surname><given-names>A</given-names></name><name><surname>Tanrikulu</surname><given-names>N</given-names></name><name><surname>Sahin</surname><given-names>M</given-names></name><name><surname>Demirsoy</surname><given-names>E</given-names></name></person-group><article-title>Aspergillus flavus endocarditis of the native mitral valve in a
bone marrow transplant patient</article-title><source>Am J Case Rep</source><year>2015</year><volume>16</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">25603977</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MS</given-names></name><name><surname>Somersan</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>HK</given-names></name><name><surname>Hartman</surname><given-names>B</given-names></name><name><surname>Wickes</surname><given-names>BL</given-names></name><name><surname>Jenkins</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Endocarditis caused by Rhodotorula infection</article-title><source>J Clin Microbiol</source><year>2014</year><volume>52</volume><issue>1</issue><fpage>374</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">24197888</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Dewey</surname><given-names>TM</given-names></name><name><surname>Mack</surname><given-names>MJ</given-names></name></person-group><article-title>Fungal endocarditis after transfemoral aortic valve
implantation</article-title><source>Catheter Cardiovasc Interv</source><year>2011</year><volume>78</volume><issue>7</issue><fpage>1017</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">21547997</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaygusuz</surname><given-names>I</given-names></name><name><surname>Mulazimoglu</surname><given-names>L</given-names></name><name><surname>Cerikcioglu</surname><given-names>N</given-names></name><name><surname>Toprak</surname><given-names>A</given-names></name><name><surname>Oktay</surname><given-names>A</given-names></name><name><surname>Korten</surname><given-names>V</given-names></name></person-group><article-title>An unusual native tricuspid valve endocarditis caused by Candida
colliculosa</article-title><source>Clin Microbiol Infect</source><year>2003</year><volume>9</volume><issue>4</issue><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">12667244</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwarakanath</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Blackburn</surname><given-names>J</given-names></name><name><surname>Castresana</surname><given-names>MR</given-names></name></person-group><article-title>A rare case of multi-chambered fungal endocarditis from a
virulent Cunninghamella infection</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>6</issue><fpage>343</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">24135836</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinstein</surname><given-names>E</given-names></name><name><surname>Noriega</surname><given-names>ER</given-names></name><name><surname>Simberkoff</surname><given-names>MS</given-names></name><name><surname>Holzman</surname><given-names>R</given-names></name><name><surname>Rahal</surname><given-names>JJ</given-names><suffix>Jr</suffix></name></person-group><article-title>Fungal endocarditis: analysis of 24 cases and review of the
literature</article-title><source>Medicine (Baltimore)</source><year>1975</year><volume>54</volume><issue>4</issue><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">1171349</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seelig</surname><given-names>MS</given-names></name><name><surname>Speth</surname><given-names>CP</given-names></name><name><surname>Kozinn</surname><given-names>PJ</given-names></name><name><surname>Taschdjian</surname><given-names>CL</given-names></name><name><surname>Toni</surname><given-names>EF</given-names></name><name><surname>Goldberg</surname><given-names>P</given-names></name></person-group><article-title>Patterns of Candida endocarditis following cardiac surgery:
Importance of early diagnosis and therapy (an analysis of 91
cases)</article-title><source>Prog Cardiovasc Dis</source><year>1974</year><volume>17</volume><issue>2</issue><fpage>125</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">4853560</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shokohi</surname><given-names>T</given-names></name><name><surname>Nouraei</surname><given-names>SM</given-names></name><name><surname>Afsarian</surname><given-names>MH</given-names></name><name><surname>Najafi</surname><given-names>N</given-names></name><name><surname>Mehdipour</surname><given-names>S</given-names></name></person-group><article-title>Fungal prosthetic valve endocarditis by Candida parapsilosis: a
case report</article-title><source>Jundishapur J Microbiol</source><year>2014</year><volume>7</volume><issue>3</issue><elocation-id/></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>ME</given-names></name><name><surname>Al-Abdely</surname><given-names>H</given-names></name><name><surname>Sandridge</surname><given-names>A</given-names></name><name><surname>Greer</surname><given-names>W</given-names></name><name><surname>Ventura</surname><given-names>W</given-names></name></person-group><article-title>Fungal endocarditis: evidence in the world literature,
1965-1995</article-title><source>Clin Infect Dis</source><year>2001</year><volume>32</volume><issue>1</issue><fpage>50</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11118386</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>S</given-names></name><name><surname>Tajima</surname><given-names>E</given-names></name><name><surname>Fukuda</surname><given-names>R</given-names></name><name><surname>Masawa</surname><given-names>T</given-names></name><name><surname>Inami</surname><given-names>S</given-names></name><name><surname>Amano</surname><given-names>H</given-names></name><etal/></person-group><article-title>Early surgical intervention and optimal medical treatment for
Candida parapsilosis endocarditis</article-title><source>Intern Med</source><year>2015</year><volume>54</volume><issue>4</issue><fpage>411</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">25748958</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>PA</given-names></name><name><surname>Madico</surname><given-names>GE</given-names></name></person-group><article-title>Polymerase chain reaction to diagnose infective endocarditis:
will it replace blood cultures?</article-title><source>Circulation</source><year>2005</year><volume>111</volume><issue>11</issue><fpage>1352</fpage><lpage>1354</lpage><pub-id pub-id-type="pmid">15781748</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrieri</surname><given-names>P</given-names></name><name><surname>Gewitz</surname><given-names>MH</given-names></name><name><surname>Gerber</surname><given-names>MA</given-names></name><name><surname>Newburger</surname><given-names>JW</given-names></name><name><surname>Dajani</surname><given-names>AS</given-names></name><name><surname>Shulman</surname><given-names>ST</given-names></name><etal/><collab>Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of
the American Heart Association Council on Cardiovascular Disease in the
Young</collab></person-group><article-title>Unique features of infective endocarditis in
childhood</article-title><source>Circulation</source><year>2002</year><volume>105</volume><issue>17</issue><fpage>2115</fpage><lpage>2126</lpage><pub-id pub-id-type="pmid">11980694</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arikan</surname><given-names>S</given-names></name><name><surname>Lozano-Chiu</surname><given-names>M</given-names></name><name><surname>Paetznick</surname><given-names>V</given-names></name><name><surname>Rex</surname><given-names>JH</given-names></name></person-group><article-title>In vitro synergy of caspofungin and amphotericin B against
Aspergillus and Fusarium spp</article-title><source>Antimicrob Agents Chemother</source><year>2002</year><volume>46</volume><issue>1</issue><fpage>245</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">11751145</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shane</surname><given-names>AL</given-names></name><name><surname>Stoll</surname><given-names>BJ</given-names></name></person-group><article-title>Recent developments and current issues in the epidemiology,
diagnosis, and management of bacterial and fungal neonatal
sepsis</article-title><source>Am J Perinatol</source><year>2013</year><volume>30</volume><issue>2</issue><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">23297182</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petraitis</surname><given-names>V</given-names></name><name><surname>Petraitiene</surname><given-names>R</given-names></name><name><surname>Sarafandi</surname><given-names>AA</given-names></name><name><surname>Kelaher</surname><given-names>AM</given-names></name><name><surname>Lyman</surname><given-names>CA</given-names></name><name><surname>Casler</surname><given-names>HE</given-names></name><etal/></person-group><article-title>Combination therapy in treatment of experimental pulmonary
aspergillosis: synergistic interaction between an antifungal triazole and an
echinocandin</article-title><source>J Infect Dis</source><year>2003</year><volume>187</volume><issue>12</issue><fpage>1834</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">12792859</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devathi</surname><given-names>S</given-names></name><name><surname>Curry</surname><given-names>B</given-names></name><name><surname>Doshi</surname><given-names>S</given-names></name></person-group><article-title>Isolated pulmonary valve infective endocarditis in a middle aged
man caused by Candida albicans: a case report</article-title><source>BMC Infect Dis</source><year>2014</year><volume>14</volume><fpage>557</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">25358458</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>PG</given-names></name><name><surname>Kauffman</surname><given-names>CA</given-names></name><name><surname>Andes</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>DK</given-names><suffix>Jr</suffix></name><name><surname>Calandra</surname><given-names>TF</given-names></name><name><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr</suffix></name><etal/><collab>Infectious Diseases Society of America</collab></person-group><article-title>Clinical practice guidelines for the management of candidiasis:
2009 update by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2009</year><volume>48</volume><issue>5</issue><fpage>503</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">19191635</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>F</given-names></name><name><surname>Penny</surname><given-names>DJ</given-names></name><name><surname>Menahem</surname><given-names>S</given-names></name><name><surname>Pawade</surname><given-names>A</given-names></name><name><surname>Karl</surname><given-names>TR</given-names></name></person-group><article-title>Surgical intervention for infective endocarditis in infancy and
childhood</article-title><source>Ann Thorac Surg</source><year>1995</year><volume>60</volume><issue>1</issue><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">7598627</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaccarino</surname><given-names>GN</given-names></name><name><surname>Nacinovich</surname><given-names>F</given-names></name><name><surname>Piccinini</surname><given-names>F</given-names></name><name><surname>Mazzetti</surname><given-names>H</given-names></name><name><surname>Segura</surname><given-names>E</given-names></name><name><surname>Navia</surname><given-names>D</given-names></name></person-group><article-title>Pacemaker endocarditis: approach for lead extraction in
endocarditis with large vegetations</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>4</issue><fpage>570</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">20305932</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>SM</given-names></name></person-group><article-title>Mycobacterial endocarditis: a comprehensive
review</article-title><source>Rev Bras Cir Cardiovasc</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">25859873</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croti</surname><given-names>UA</given-names></name><name><surname>Braile</surname><given-names>DM</given-names></name><name><surname>De Marchi</surname><given-names>CH</given-names></name><name><surname>Beani</surname><given-names>L</given-names></name></person-group><article-title>Breastfeeding baby with fungal endocarditis at the right
ventricle outflow tract</article-title><source>Rev Bras Cir Cardiovasc</source><year>2006</year><volume>21</volume><issue>2</issue><fpage>225</fpage><lpage>226</lpage></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denning</surname><given-names>DW</given-names></name><name><surname>Stevens</surname><given-names>DA</given-names></name></person-group><article-title>Antifungal and surgical treatment of invasive aspergillosis:
review of 2,121 published cases</article-title><source>Rev Infect Dis</source><year>1990</year><volume>12</volume><issue>6</issue><fpage>1147</fpage><lpage>1201</lpage><pub-id pub-id-type="pmid">2267490</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalokhe</surname><given-names>AS</given-names></name><name><surname>Rouphael</surname><given-names>N</given-names></name><name><surname>El Chami</surname><given-names>MF</given-names></name><name><surname>Workowski</surname><given-names>KA</given-names></name><name><surname>Ganesh</surname><given-names>G</given-names></name><name><surname>Jacob</surname><given-names>JT</given-names></name></person-group><article-title>Aspergillus endocarditis: a review of the
literature</article-title><source>Int J Infect Dis</source><year>2010</year><volume>14</volume><issue>12</issue><fpage>e1040</fpage><lpage>e1047</lpage><pub-id pub-id-type="pmid">21036091</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinbach</surname><given-names>WJ</given-names></name><name><surname>Perfect</surname><given-names>JR</given-names></name><name><surname>Cabell</surname><given-names>CH</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name><name><surname>Corey</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>JS</given-names></name><etal/></person-group><article-title>A meta-analysis of medical versus surgical therapy for Candida
endocarditis</article-title><source>J Infect</source><year>2005</year><volume>51</volume><issue>3</issue><fpage>230</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">16230221</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornely</surname><given-names>OA</given-names></name><name><surname>Bassetti</surname><given-names>M</given-names></name><name><surname>Calandra</surname><given-names>T</given-names></name><name><surname>Garbino</surname><given-names>J</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><name><surname>Lortholary</surname><given-names>O</given-names></name><etal/><collab>ESCMID Fungal Infection Study Group</collab></person-group><article-title>ESCMID* guideline for the diagnosis and management of Candida
diseases 2012: non-neutropenic adult patients</article-title><source>Clin Microbiol Infect</source><year>2012</year><volume>18</volume><issue>Suppl 7</issue><fpage>19</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">23137135</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seelig</surname><given-names>MS</given-names></name><name><surname>Kozinin</surname><given-names>PJ</given-names></name><name><surname>Goldberg</surname><given-names>P</given-names></name><name><surname>Berger</surname><given-names>AR</given-names></name></person-group><article-title>Fungal endocarditis: patients at risk and their
treatment</article-title><source>Postgrad Med J</source><year>1979</year><volume>55</volume><issue>647</issue><fpage>632</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">392478</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pana</surname><given-names>ZD</given-names></name><name><surname>Dotis</surname><given-names>J</given-names></name><name><surname>Iosifidis</surname><given-names>E</given-names></name><name><surname>Roilides</surname><given-names>E</given-names></name></person-group><article-title>Fungal endocarditis in neonates: a review of seventy-one cases
(1971-2013)</article-title><source>Pediatr Infect Dis J</source><year>2015</year><volume>34</volume><issue>8</issue><fpage>803</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">25933094</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzo</surname><given-names>PA</given-names></name><name><surname>Robichaud</surname><given-names>KJ</given-names></name><name><surname>Gill</surname><given-names>FA</given-names></name><name><surname>Witebsky</surname><given-names>FG</given-names></name></person-group><article-title>Empiric antibiotic and antifungal therapy for cancer patients
with prolonged fever and granulocytopenia</article-title><source>Am J Med</source><year>1982</year><volume>72</volume><issue>1</issue><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">7058815</pub-id></element-citation></ref></ref-list></back></article>